Atossa Therapeutics
Stock Forecast, Prediction & Price Target
Atossa Therapeutics Financial Estimates
Atossa Therapeutics Revenue Estimates
Atossa Therapeutics EBITDA Estimates
Atossa Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $54.46M Low: $54.46M High: $54.46M avg. 0% | Avg: $121.27M Low: $121.27M High: $121.27M avg. 122.67% | Avg: $341.03M Low: $341.03M High: $341.03M avg. 181.21% |
Net Income
% change YoY
| $-20.60M N/A | $-26.22M -27.28% | $-30.09M -14.73% | Avg: $-35.64M Low: $-39.08M High: $-31.52M avg. -18.45% | Avg: $-1.71M Low: $-34.04M High: $83.21M avg. 95.20% | Avg: $51.27M Low: $51.27M High: $51.27M avg. 3097.87% | Avg: $180.29M Low: $180.29M High: $180.29M avg. 251.63% |
EBITDA
% change YoY
| $-20.49M N/A | $-27.69M -35.09% | $-31.35M -13.22% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.18 N/A | -$0.21 -16.66% | -$0.24 -14.28% | Avg: -$0.28 Low: -$0.31 High: -$0.25 avg. -14.58% | Avg: $0.06 Low: -$0.27 High: $0.66 avg. 120.60% | Avg: $0.41 Low: $0.41 High: $0.41 avg. 617.61% | Avg: $1.43 Low: $1.43 High: $1.43 avg. 251.63% |
Operating Expenses
% change YoY
| $20.52M N/A | $27.69M 34.93% | $31.37M 13.31% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Atossa Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 856.56% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -39.08M, average is -35.64M and high is -31.52M.
What is Atossa Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 75.97% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Atossa Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 243.81% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.31, average is -$0.28 and high is $-0.25.
What is the best performing analyst?
In the last twelve months analysts have been covering Atossa Therapeutics stock. The most successful analyst is Louise Chen.